Spiroxatrine
Spiroxatrine is a drug which acts as a selective antagonist at both the 5-HT1A receptor and the α2C adrenergic receptor.[1] It is an analog of spiperone and also has some dopamine antagonist effects.
![]() | |
Names | |
---|---|
IUPAC name
8-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
MeSH | Spiroxatrine |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C22H25N3O3 |
Molar mass | 379.460 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
Synthesis
Note well that the piperidine intermediate has a venerable history & has been incorporated into in the synthesis of the following drugs: Spiperone, Fluspirilene, Ro65-6570, RP-23618, Spirilene, Spiramide, R 5260 [1109-69-9], PCP-Antipsychotic mixture. Although it looks like most agents are antipsychotics, more applications might be possible. Indeed, manipulations to the molecular structure meant some of the agents behave as opioids.
![](../I/Spiroxatrine_synthesis.svg.png.webp)
Convergent synthesis between 2-Bromomethyl-1,4-benzodioxane [2164-34-3] (1) and 1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one [1021-25-6] (2) completes the synthesis of Spiroxatrine (3)
References
- Terrón, J. A.; Ibarra, M; Ransanz, V; Hong, E; Villalón, C. M. (1993). "The alpha-antiadrenergic properties of spiroxatrine, a ligand of serotonergic 5-HT1A receptors". Archivos del Instituto de Cardiología de México. 63 (4): 289–95. PMID 8105762.
- Janssen Paul Adriaan Jan, U.S. Patent 3,238,216 (1966 to Res Lab Dr C Janssen N V).